No Matches Found
No Matches Found
No Matches Found
Mukka Proteins Ltd
Mukka Proteins Ltd is Rated Sell
Mukka Proteins Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 April 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook.
Mukka Proteins Ltd is Rated Sell
Mukka Proteins Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 April 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook.
Mukka Proteins Ltd Technical Momentum Shifts Amid Mixed Market Returns
Mukka Proteins Ltd, a micro-cap player in the FMCG sector, has exhibited a subtle shift in its technical momentum, moving from a strongly bearish stance to a mildly bearish outlook. Despite a modest day gain of 1.39% to close at ₹22.60, the stock’s technical indicators present a complex picture, reflecting cautious optimism tempered by persistent downward pressures.
Mukka Proteins Gains 4.92%: 2 Key Factors Driving the Weekly Recovery
Mukka Proteins Ltd experienced a volatile week, ultimately closing with a 4.92% gain from Rs.19.71 to Rs.20.68, outperforming the Sensex which declined by 0.29% over the same period. The stock’s trajectory was marked by a sharp fall to an all-time low on 30 March, followed by a robust rebound in the subsequent sessions, reflecting mixed investor sentiment amid ongoing fundamental challenges.
Mukka Proteins Ltd is Rated Sell
Mukka Proteins Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 April 2026, providing investors with an up-to-date view of the company's fundamentals, returns, and market performance.
Mukka Proteins Ltd Extends Losing Streak to Three Sessions, Touches All-Time Low
For the third consecutive session, Mukka Proteins Ltd has closed lower, hitting a fresh all-time low of Rs 18.44 on 30 Mar 2026. This decline comes amid broader sector weakness but notably outpaces the Aquaculture sector's fall, signalling stock-specific pressures.
Mukka Proteins Ltd Falls to 52-Week Low of Rs 18.74 as Sell-Off Deepens
For the third consecutive session, Mukka Proteins Ltd has closed lower, culminating in a fresh 52-week low of Rs 18.74 on 30 Mar 2026. This decline extends the stock’s year-long slide to over 42%, markedly underperforming the broader Sensex, which has fallen just 6.23% over the same period.
Mukka Proteins Declines 6.37%: Four Key Factors Behind the Steep Slide
Mukka Proteins Ltd’s stock endured a challenging week from 23 to 27 March 2026, declining by 6.37% to close at Rs.19.71, significantly underperforming the Sensex’s 1.46% fall over the same period. The stock hit fresh 52-week and all-time lows amid persistent financial headwinds, technical weakness, and subdued investor sentiment, despite a brief positive quarterly earnings report in December 2025.
Mukka Proteins Ltd Falls to 52-Week Low of Rs 19.93 Amidst Prolonged Downtrend
For the second consecutive session, Mukka Proteins Ltd closed lower, slipping to a fresh 52-week low of Rs 19.93 on 27 Mar 2026, marking a significant 39.02% decline over the past year despite a sector that has also faced pressure.
Mukka Proteins Ltd Slides to All-Time Low Amid Mixed Financial Signals
Mukka Proteins Ltd’s stock price has declined to an all-time low of Rs.20 on 27 Mar 2026, marking a significant milestone in its ongoing downward trajectory. The micro-cap FMCG company’s shares have underperformed both the broader market and its sector peers over multiple timeframes, reflecting persistent pressures on its financial and market standing.
Mukka Proteins Ltd Falls to 52-Week Low of Rs 20 as Sell-Off Deepens
For the fourth consecutive session, Mukka Proteins Ltd has declined, culminating in a fresh 52-week low of Rs 20 on 24 Mar 2026. This marks a significant 42.7% drop from its 52-week high of Rs 34.89, underscoring persistent selling pressure amid a challenging market backdrop.
Mukka Proteins Ltd Extends Losing Streak to Four Sessions, Hits All-Time Low at Rs 20
For the fourth consecutive session, Mukka Proteins Ltd has closed lower, reaching a fresh all-time low of Rs 20 on 24 Mar 2026, marking a 7.56% decline over this period amid broader market resilience.
Mukka Proteins Ltd is Rated Sell
Mukka Proteins Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 March 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook.
Mukka Proteins Ltd is Rated Sell
Mukka Proteins Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.
Mukka Proteins Ltd is Rated Sell by MarketsMOJO
Mukka Proteins Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 March 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook.
Mukka Proteins Ltd is Rated Sell
Mukka Proteins Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 November 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Mukka Proteins Ltd Quality Parameters Deteriorate Amidst Challenging FMCG Landscape
Mukka Proteins Ltd has seen its quality grade downgraded from average to below average, reflecting a deterioration in key business fundamentals. The downgrade comes amid declining sales and earnings growth, elevated leverage ratios, and modest returns on capital, signalling caution for investors in this FMCG micro-cap stock.
Are Mukka Proteins Ltd latest results good or bad?
Mukka Proteins Ltd's latest Q3 FY26 results show strong revenue growth of 167.19% sequentially and 115.57% year-on-year, but profitability is a concern with declining operating margins and a net profit decrease of 9.56% compared to last year. The company faces challenges in maintaining profitability amid high debt levels and interest costs.
Mukka Proteins Gains 0.36%: 2 Key Factors Driving the Weekly Move
Mukka Proteins Ltd recorded a modest weekly gain of 0.36% to close at Rs.24.86 on 13 February 2026, outperforming the Sensex which declined by 0.54% over the same period. The stock showed resilience amid mixed market conditions, buoyed by a strong quarterly turnaround and robust revenue growth despite margin pressures. This review analyses the key events and price movements that shaped the stock’s performance during the week ending 13 February 2026.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
